Michael J Rieder (Michael Rieder)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 16

Top Topics

Top Venues

British journal of clinical pharmacology

Cambridge prisms. Precision medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Michael J Rieder, Andrej Belančić
Past, present and future of drug safety: Editorial. British journal of clinical pharmacology (2024)
Michael J Rieder, Andrej Belančić
Past, present and future of drug safety: Editorial. British journal of clinical pharmacology 90 (8) (2024)
Michael J Rieder, Andrej Belančić
Past, present and future of drug safety: Editorial. British journal of clinical pharmacology 90 (8) (2024)
Abdelbaset Elzagallaai, Charlotte Barker, Tamorah Lewis, Ronald Cohn, Michael J Rieder
Advancing Precision Medicine in Paediatrics: Past, present and future. Cambridge prisms. Precision medicine 1 (2023)
Abdelbaset Elzagallaai, Charlotte Barker, Tamorah Lewis, Ronald Cohn, Michael J Rieder
Advancing Precision Medicine in Paediatrics: Past, present and future. Cambridge prisms. Precision medicine 1 (2023)
Sung Ho Um, Awatif Abuzgaia, Michael J Rieder
Comparison of the Liverpool Causality Assessment Tool versus the Naranjo Scale for Predicting the Likelihood of an Adverse Drug Reaction: A Retrospective Cohort Study. British journal of clinical pharmacology (2023)
Yong Jin Lim, Steven G Xiu, M Sara Kuruvilla, Eric Winquist, Stephen Welch, Morgan Black, Lauren N Faught, Jasmine Lee, Michael J Rieder, Tom D Blydt-Hansen, Michael Zappitelli, Bradley L Urquhart
Metabolomic identification of predictive and early biomarkers of cisplatin-induced acute kidney injury in adult head and neck cancer patients. British journal of clinical pharmacology (2023)
Sung Ho Um, Awatif Abuzgaia, Michael J Rieder
Comparison of the Liverpool Causality Assessment Tool vs. the Naranjo Scale for predicting the likelihood of an adverse drug reaction: A retrospective cohort study. British journal of clinical pharmacology (2023)
Yong Jin Lim, Steven G Xiu, M Sara Kuruvilla, Eric Winquist, Stephen Welch, Morgan Black, Lauren N Faught, Jasmine Lee, Michael J Rieder, Tom D Blydt-Hansen, Michael Zappitelli, Bradley L Urquhart
Metabolomic Identification of Predictive and Early Biomarkers of Cisplatin-induced Acute Kidney Injury in Adult Head and Neck Cancer Patients. British journal of clinical pharmacology (2023)
Blanca R Del Pozzo-Magaña, Michael J Rieder, Facundo Garcia-Bournissen, Alejandro Lazo-Langner
Drug reaction with eosinophilia and systemic symptoms (DRESS): A tertiary care centre retrospective study. British journal of clinical pharmacology 88 (9) (2022)
Michael J Rieder, Garcia-Bournissen Facundo
Paediatric and obstetrical pharmacology - Pushing the frontier forward. British journal of clinical pharmacology 88 (10) (2022)
Abdelbaset A Elzagallaai, Michael J Rieder
Pathophysiology of drug hypersensitivity. British journal of clinical pharmacology (2022)
Charlotte I S Barker, Gabriella Groeneweg, Anke H Maitland-van der Zee, Michael J Rieder, Daniel B Hawcutt, Tim J Hubbard, Jesse J Swen, Bruce C Carleton
Pharmacogenomic testing in paediatrics: Clinical implementation strategies. British journal of clinical pharmacology 88 (10) (2022)
Spoorthy Kulkarni, Michael J Rieder, Robert Likić
Quo vadis (where are you going) pharmacovigilance? British journal of clinical pharmacology (2022)
Abdelbaset A Elzagallaai, Michael J Rieder
Pathophysiology of Drug Hypersensitivity. British journal of clinical pharmacology (2022)
Charlotte Moore-Hepburn, Michael J Rieder
Paediatric pharmacotherapy and drug regulation: Moving past the therapeutic orphan. British journal of clinical pharmacology (2021)